7 EFPIA Companies Revised R&D Strategies after April Pricing Overhaul: Survey

November 9, 2018
EFPIA President-Elect Jean-Christophe Tellier (right), EFPIA Japan Chairman Ole Moelskov Bech at Tokyo Press Conference Japan’s drug pricing overhaul in April has prompted 50% of EFPIA Japan member companies affected by policy changes to revise their R&D strategy in the...read more